Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ly49A allelic variation and MHC class I specificity.

I K Mehta1, J Wang, J Roland

  • 1Department of Medicine, Center for Arthritis and Related Diseases, Box 8045, Washington University School of Medicine and Howard Hughes Medical Institute, 660 South Euclid Avenue, St. Louis, MO 63110, USA.

Immunogenetics
|October 31, 2001
PubMed
Summary

Natural killer (NK) cell receptors in the Ly49 family show functionally significant variations. Different Ly49A alleles impact NK cell inhibition of H2Dd targets, highlighting allelic polymorphism in immune receptor function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What are the greatest opportunities for innovation to improve access to and quality of palliative care services to children? A qualitative interview study.

BMC palliative care·2025
Same author

Corrigendum to "Volunteering to improve health worldwide. Current trends in Out of Programme Experience/Training in the UK 2014" [J. Epidemiol. Glob. Health 5 (2015) 295-296].

Journal of epidemiology and global health·2016
Same author

Volunteering to improve health worldwide. Current trends in Out of Programme Experience/Training in the UK 2014.

Journal of epidemiology and global health·2015
Same author

CD300b regulates the phagocytosis of apoptotic cells via phosphatidylserine recognition.

Cell death and differentiation·2014
Same author

[A stochastic test for validity control of visual acuity statements].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2009
Same author

In vivo visualization of 111In labeled CD133+ peripheral blood stem cells after intracoronary administration in patients with chronic ischemic heart disease.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2007

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • The Ly49 family comprises natural killer (NK) cell receptors encoded by a polygenic locus.
  • Allelic variations of Ly49 receptors are known, with expression regulation.
  • Ly49A, particularly the C57BL/6 variant, functions as an inhibitory receptor binding H2Dd.

Purpose of the Study:

  • To investigate the functional consequences of allelic differences in Ly49A.
  • To compare the reactivity and inhibitory function of various Ly49A allelic variants.

Main Methods:

  • Cloning of Ly49a allelic variants from different inbred mouse strains.
  • Generation of stable transfectants expressing Ly49A variants.
  • Testing reactivity with specific monoclonal antibodies and H2Dd tetramers.

Related Experiment Videos

  • Cytotoxicity assays using IL-2-activated NK cells.

    • Main Results:

    • Transfectants expressing different Ly49A alleles showed varied reactivity to monoclonal antibodies.
    • Despite binding H2Dd tetramers, Ly49A+ NK cells from different strains exhibited distinct levels of inhibition against H2Dd targets.
    • Functional differences in inhibition correlate with structural data of the Ly49A-H2Dd complex.

    Conclusions:

    • The Ly49 family exhibits functionally significant allelic polymorphism.
    • This polymorphism contributes to the diversity of NK cell receptor repertoire and function.
    • Understanding Ly49A allelic variants is crucial for comprehending NK cell-mediated immunity.